Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis \(AD\)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07438509
What this trial is testing

Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema

Who this might be right for
Atopic Dermatitis (AD)Atopic Eczema
Jinnah Postgraduate Medical Centre 270
Early research (Phase 1)Looking for participantsNCT07693738
What this trial is testing

A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
AD
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 96
Large-scale testing (Phase 3)Study completedNCT06224192
What this trial is testing

A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amgen 151
Post-approval studies (Phase 4)Study completedNCT04033367
What this trial is testing

SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"

Who this might be right for
Atopic Dermatitis
Sanofi 188
Not applicableEnrolling By InvitationNCT07503197
What this trial is testing

A Study on the Efficacy of 2% Cholesterol Cream in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)CholesterolSkin Barrier to Water Loss+3 more
Institute of Dermatology, Thailand 30
Not applicableLooking for participantsNCT05391061
What this trial is testing

Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 1,100
Not applicableStudy completedNCT04728269
What this trial is testing

Exploratory Study on Lactibiane Topic AD on Skin Flora and Barrier Reinforcement in Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
PiLeJe 10
Post-approval studies (Phase 4)Ended earlyNCT03389893
What this trial is testing

Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
National Institute of Allergy and Infectious Diseases (NIAID) 72
Large-scale testing (Phase 3)Study completedNCT03345914
What this trial is testing

Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Regeneron Pharmaceuticals 367
Not applicableLooking for participantsNCT06238765
What this trial is testing

CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry

Who this might be right for
Atopic Dermatitis
CorEvitas 1,500
Testing effectiveness (Phase 2)Active Not RecruitingNCT07693400
What this trial is testing

Topical Chinese Medicine and Exosome Mechanisms for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Taiwan Municipal An-Nan Hospital-China Medical University 44
Not applicableLooking for participantsNCT07544862
What this trial is testing

Stapokibart Injection in Patients With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis (AD)
Chengdu Kangnuoxing Biopharma,Inc. 1,000
Large-scale testing (Phase 3)Study completedNCT05724199
What this trial is testing

A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 746
Large-scale testing (Phase 3)Study completedNCT03346434
What this trial is testing

Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)

Who this might be right for
Dermatitis, Atopic
Regeneron Pharmaceuticals 202
Testing effectiveness (Phase 2)Ended earlyNCT05984784
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)

Who this might be right for
Atopic DermatitisModerate-to-severe Atopic DermatitisAD
Inmagene LLC 13
Testing effectiveness (Phase 2)Ended earlyNCT03948334
What this trial is testing

Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 123
Testing effectiveness (Phase 2)Active Not RecruitingNCT07105488
What this trial is testing

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Bluefin Biomedicine, Inc. 225
Not applicableStudy completedNCT05517850
What this trial is testing

Therapist-guided vs Self-guided CBT for AD: Non-inferiority Trial

Who this might be right for
Atopic Dermatitis
Karolinska Institutet 168
Post-approval studies (Phase 4)WithdrawnNCT07187089
What this trial is testing

Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With Dupilumab

Who this might be right for
Severe Atopic Dermatitis (AD)
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT07445919
What this trial is testing

A Clinical Study to Evaluate SM17 for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
SinoMab BioScience Ltd 200
Next Page